𝔖 Bobbio Scriptorium
✦   LIBER   ✦

9091 Activity, safety and compliance of sequential chemotherapy with cisplatin (CDDP) plus oral vinorelbine (VNRos) followed by three-weekly docetaxel (DOC) as first-line treatment for advanced non-small cell lung cancer (NSCLC): a single-centre phase II study

✍ Scribed by Teragni, C.; Palumbo, R.; Bernardo, A.; Strada, M.R.; Poggi, G.; Amatu, A.; Montagna, B.; Tagliaferri, B.; Sottotetti, F.; Bernardo, G.


Book ID
122862280
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
46 KB
Volume
7
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.